VALBENAZIN-DIHYDROCHLORIDSALZE UND POLYMORPHE DAVON
European patent · EP3875459 · In force
Register entry
- Publication number
- EP3875459
- Application number
- EP21153302
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Oct 28, 2016
- Published
- Sep 8, 2021
- Granted
- Dec 13, 2023
- Protection ends at the latest
- Oct 27, 2036
- Next annual fee due
- Oct 31, 2027
- IPC classes
- C07D 471/04 (2006.01)A61K 31/4375 (2006.01)A61P 25/00 (2006.01)A61P 25/14 (2006.01)
- Priority
- US 201562249074 P 30.10.2015
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Nov 1, 2026
Next annual fee due on
- Next annual fee due on
- 31.10.2026 → 31.10.2027
Published in Swissreg on 01.11.2026
- Jul 14, 2026
Holder’s address changed
- Owner
- Neurocrine Biosciences, Inc., 12780 El Camino Real, San Diego, California 92130, USA → NEUROCRINE BIOSCIENCES, INC., 6027 Edgewood Bend Court, San Diego, CA 92130, USA
Published in Swissreg on 14.07.2026
- Nov 1, 2025
Next annual fee due on
- Next annual fee due on
- 31.10.2025 → 31.10.2026
Published in Swissreg on 01.11.2025
- Nov 1, 2024
Next annual fee due on
- Next annual fee due on
- 31.10.2024 → 31.10.2025
Published in Swissreg on 01.11.2024
- Oct 23, 2024
Change
Published in Swissreg on 23.10.2024
- Feb 8, 2024
Agent entered
- Representative
- MICHELI & CIE SA, 122, rue de Genève,, CP 61, 1226 Thônex
Published in Swissreg on 08.02.2024
- Dec 13, 2023
Granted
Published in Swissreg on 13.12.2023
Parties
Inventor
San Diego, California 92104, US
Cambridge, CB1 9YB, GB
Eugene, Oregon 97405, US
Cambridge, CB23 6AU, GB
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.